Petmed Express Stock Price, News & Analysis (NASDAQ:PETS)

$46.87 +1.18 (+2.58 %)
(As of 02/22/2018 04:12 AM ET)
Previous Close$45.69
Today's Range$45.84 - $48.21
52-Week Range$19.21 - $57.80
Volume601,300 shs
Average Volume798,503 shs
Market Capitalization$965.57 million
P/E Ratio26.04
Dividend Yield2.19%
Beta0.95

About Petmed Express (NASDAQ:PETS)

Petmed Express logoPetMed Express, Inc. (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies. Its products include brands of medication, such as Frontline Plus, K9 Advantix II, Advantage II, Heartgard Plus, Sentinel, Revolution and Rimadyl. It also offers additional pet supplies for sale on its Website, which are drop shipped to its customers by third parties. These pet supplies include food, beds, crates, stairs, strollers and other pet supplies. Its products included Non-Prescription Medications (Over the Counter (OTC)) and supplies, and Prescription Medications (Rx). Its customers are located in California, Florida, Texas, New York, Virginia and Georgia, among others.

Receive PETS News and Ratings via Email

Sign-up to receive the latest news and ratings for PETS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Retail - Drugs without Grocery
Sub-IndustryInternet Retail
SectorNon-Cyclical Consumer Goods & Services
SymbolNASDAQ:PETS
CUSIP71638210
Phone+1-561-4264444

Debt

Debt-to-Equity RatioN/A
Current Ratio4.24%
Quick Ratio3.36%

Price-To-Earnings

Trailing P/E Ratio26.0388888888889
Forward P/E Ratio27.57
P/E Growth2.6

Sales & Book Value

Annual Sales$249.18 million
Price / Sales3.87
Cash Flow$1.30 per share
Price / Cash36.01
Book Value$5.34 per share
Price / Book8.78

Profitability

Trailing EPS$1.80
Net Income$23.81 million
Net Margins12.84%
Return on Equity34.04%
Return on Assets27.74%

Miscellaneous

Employees187
Outstanding Shares20,600,000

Petmed Express (NASDAQ:PETS) Frequently Asked Questions

What is Petmed Express' stock symbol?

Petmed Express trades on the NASDAQ under the ticker symbol "PETS."

How often does Petmed Express pay dividends? What is the dividend yield for Petmed Express?

Petmed Express announced a quarterly dividend on Monday, January 22nd. Shareholders of record on Monday, February 5th will be given a dividend of $0.25 per share on Friday, February 16th. This represents a $1.00 dividend on an annualized basis and a yield of 2.13%. The ex-dividend date of this dividend is Friday, February 2nd. This is a positive change from Petmed Express's previous quarterly dividend of $0.20. View Petmed Express' Dividend History.

How were Petmed Express' earnings last quarter?

Petmed Express Inc (NASDAQ:PETS) released its earnings results on Monday, January, 22nd. The company reported $0.44 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.33 by $0.11. The business had revenue of $60.10 million for the quarter, compared to the consensus estimate of $56.76 million. Petmed Express had a return on equity of 34.04% and a net margin of 12.84%. The business's revenue was up 13.6% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.24 earnings per share. View Petmed Express' Earnings History.

When will Petmed Express make its next earnings announcement?

Petmed Express is scheduled to release their next quarterly earnings announcement on Monday, May, 7th 2018. View Earnings Estimates for Petmed Express.

Where is Petmed Express' stock going? Where will Petmed Express' stock price be in 2018?

5 equities research analysts have issued 1-year price targets for Petmed Express' shares. Their forecasts range from $19.00 to $58.00. On average, they expect Petmed Express' share price to reach $41.00 in the next year. View Analyst Ratings for Petmed Express.

Who are some of Petmed Express' key competitors?

Who are Petmed Express' key executives?

Petmed Express' management team includes the folowing people:

  • Robert C. Schweitzer, Independent Chairman of the Board (Age 71)
  • Menderes Akdag, President, Chief Executive Officer, Director (Age 56)
  • Bruce S. Rosenbloom, Chief Financial Officer, Treasurer (Age 48)
  • Frank J. Formica, Independent Director (Age 73)
  • Gian M. Fulgoni, Independent Director (Age 69)
  • Ronald J. Korn, Independent Director (Age 77)

Who owns Petmed Express stock?

Petmed Express' stock is owned by a number of of institutional and retail investors. Top institutional investors include BlackRock Inc. (12.56%), Renaissance Technologies LLC (7.94%), Acadian Asset Management LLC (2.30%), Teachers Advisors LLC (1.86%), Bank of New York Mellon Corp (1.67%) and Penserra Capital Management LLC (1.59%). Company insiders that own Petmed Express stock include Bruce S Rosenbloom, Frank J Formica, Gian Fulgoni, Menderes Akdag, Robert C Schweitzer and Ronald J Korn. View Institutional Ownership Trends for Petmed Express.

Who sold Petmed Express stock? Who is selling Petmed Express stock?

Petmed Express' stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, Deutsche Bank AG, Acadian Asset Management LLC, Schroder Investment Management Group, Renaissance Technologies LLC, Gotham Asset Management LLC, Bank of Montreal Can and Goldman Sachs Group Inc.. Company insiders that have sold Petmed Express company stock in the last year include Bruce S Rosenbloom, Frank J Formica, Gian Fulgoni, Menderes Akdag, Robert C Schweitzer and Ronald J Korn. View Insider Buying and Selling for Petmed Express.

Who bought Petmed Express stock? Who is buying Petmed Express stock?

Petmed Express' stock was purchased by a variety of institutional investors in the last quarter, including Teachers Advisors LLC, Allianz Asset Management GmbH, Penserra Capital Management LLC, Landscape Capital Management L.L.C., WINTON GROUP Ltd, Maverick Capital Ltd., First Trust Advisors LP and BlackRock Inc.. View Insider Buying and Selling for Petmed Express.

How do I buy Petmed Express stock?

Shares of Petmed Express can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Petmed Express' stock price today?

One share of Petmed Express stock can currently be purchased for approximately $46.87.

How big of a company is Petmed Express?

Petmed Express has a market capitalization of $965.57 million and generates $249.18 million in revenue each year. The company earns $23.81 million in net income (profit) each year or $1.80 on an earnings per share basis. Petmed Express employs 187 workers across the globe.

How can I contact Petmed Express?

Petmed Express' mailing address is 420 S Congress Ave, DELRAY BEACH, FL 33445-4693, United States. The company can be reached via phone at +1-561-4264444.


MarketBeat Community Rating for Petmed Express (PETS)

Community Ranking:  1.6 out of 5 (star)
Outperform Votes:  81 (Vote Outperform)
Underperform Votes:  179 (Vote Underperform)
Total Votes:  260
MarketBeat's community ratings are surveys of what our community members think about Petmed Express and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Petmed Express (NASDAQ:PETS) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldBuy
Consensus Rating Score: 2.202.202.202.50
Ratings Breakdown: 1 Sell Rating(s)
2 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
2 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
2 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $41.00$41.00$40.00$47.00
Price Target Upside: 12.77% downside12.77% downside14.55% upside29.76% upside

Petmed Express (NASDAQ:PETS) Consensus Price Target History

Price Target History for Petmed Express (NASDAQ:PETS)

Petmed Express (NASDAQ:PETS) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/3/2018Northcoast ResearchSet Price TargetBuy$58.00HighView Rating Details
10/27/2017Noble FinancialReiterated RatingHoldN/AView Rating Details
10/2/2017Credit Suisse GroupReiterated RatingUnderperform$19.00LowView Rating Details
8/24/2017SidotiUpgradeNeutral -> Buy$47.00HighView Rating Details
8/21/2017Craig HallumReiterated RatingHold$43.00 -> $40.00HighView Rating Details
(Data available from 2/22/2016 forward)

Earnings

Petmed Express (NASDAQ:PETS) Earnings History and Estimates Chart

Earnings by Quarter for Petmed Express (NASDAQ:PETS)

Petmed Express (NASDAQ PETS) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/7/2018$0.47N/AView Earnings Details
1/22/2018Q3 2018$0.33$0.44$56.76 million$60.10 millionViewListenView Earnings Details
10/23/2017Q2 2018$0.30$0.43$63.41 million$66.70 millionViewN/AView Earnings Details
7/24/2017Q1 2018$0.38$0.45$77.32 million$79.66 millionViewN/AView Earnings Details
5/8/2017Q4 17$0.26$0.37$56.53 million$63.03 millionViewListenView Earnings Details
1/23/2017Q3 2017$0.25$0.24$52.70 million$52.90 millionViewN/AView Earnings Details
10/24/2016Q2$0.26$0.24$58.47 million$60.80 millionViewN/AView Earnings Details
7/25/2016Q1$0.31$0.32$72.90 million$72.49 millionViewN/AView Earnings Details
5/9/2016Q4$0.25$0.27$50.20 million$55.40 millionViewN/AView Earnings Details
1/25/2016Q316$0.25$0.24$49.28 million$50.90 millionViewListenView Earnings Details
10/19/2015Q216$0.20$0.22$58.34 million$56.70 millionViewListenView Earnings Details
7/20/2015Q116$0.28$0.29$73.04 million$71.60 millionViewN/AView Earnings Details
5/4/2015Q415$0.25$0.25$49.11 million$50.00 millionViewN/AView Earnings Details
1/20/2015Q315$0.24$0.24$49.26 million$49.30 millionViewN/AView Earnings Details
10/20/2014Q215$0.21$0.19$61.22 million$57.60 millionViewListenView Earnings Details
7/21/2014Q115$0.25$0.25$74.25 million$72.50 millionViewN/AView Earnings Details
5/5/2014Q414$0.22$0.23$55.02 million$48.60 millionViewN/AView Earnings Details
1/21/2014Q214$0.23$0.23$52.06 million$50.10 millionViewN/AView Earnings Details
10/21/2013Q213$0.22$0.20$60.33 million$80.50 millionViewN/AView Earnings Details
7/22/2013Q1 2013$0.22$0.24$69.55 million$74.20 millionViewN/AView Earnings Details
5/6/2013Q4 2012$0.21$0.23$55.31 million$51.10 millionViewN/AView Earnings Details
1/22/2013Q3 2012$0.17$0.23$49.97 million$49.60 millionViewN/AView Earnings Details
10/22/2012$0.17$0.20ViewN/AView Earnings Details
7/23/2012$0.23$0.20ViewN/AView Earnings Details
5/7/2012$0.18$0.20ViewN/AView Earnings Details
1/23/2012$0.16$0.19ViewN/AView Earnings Details
10/24/2011$0.15$0.19ViewN/AView Earnings Details
7/18/2011$0.24$0.22ViewN/AView Earnings Details
5/9/2011$0.23$0.19ViewN/AView Earnings Details
1/24/2011$0.20$0.20ViewN/AView Earnings Details
10/18/2010Q2 2011$0.26$0.22ViewN/AView Earnings Details
7/19/2010Q1 2011$0.38$0.32ViewN/AView Earnings Details
5/10/2010Q4 2010$0.27$0.27ViewN/AView Earnings Details
1/19/2010Q3 2010$0.23$0.25ViewN/AView Earnings Details
10/19/2009Q2 2010$0.28$0.28ViewN/AView Earnings Details
7/20/2009Q1 2010$0.31$0.36ViewN/AView Earnings Details
5/11/2009Q4 2009$0.22$0.25ViewN/AView Earnings Details
1/20/2009Q3 2009$0.20$0.21ViewN/AView Earnings Details
10/20/2008Q2 2009$0.20$0.25ViewN/AView Earnings Details
7/21/2008Q1 2009$0.27$0.28ViewN/AView Earnings Details
5/12/2008Q4 2008$0.18$0.20ViewN/AView Earnings Details
1/22/2008Q3 2008$0.14$0.18ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Petmed Express (NASDAQ:PETS) Earnings Estimates

2018 EPS Consensus Estimate: $1.50
2019 EPS Consensus Estimate: $1.90
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20182$0.40$0.40$0.40
Q2 20182$0.28$0.28$0.28
Q3 20182$0.33$0.45$0.39
Q4 20182$0.43$0.43$0.43
Q1 20192$0.51$0.58$0.55
Q2 20192$0.42$0.50$0.46
Q3 20192$0.35$0.49$0.42
Q4 20192$0.45$0.49$0.47
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Petmed Express (NASDAQ:PETS) Dividend Information

Most Recent Dividend:2/16/2018
Annual Dividend:$1.00
Dividend Yield:2.13%
Payout Ratio:55.56% (Trailing 12 Months of Earnings)
58.82% (Based on This Year's Estimates)
51.55% (Based on Next Year's Estimates)
Dividend Payments by Quarter for Petmed Express (NASDAQ:PETS)

Petmed Express (NASDAQ:PETS) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
1/22/2018quarterly$0.250.00469571750563486%2/2/20182/5/20182/16/2018
10/24/2017quarterly$0.202.08%11/3/201711/6/201711/17/2017
7/24/2017quarterly$0.201.66%8/3/20178/7/20178/18/2017
5/8/2017quarterly$0.205/17/20175/19/20175/26/2017
1/23/2017quarterly$0.193.61%2/2/20172/6/20172/17/2017
10/24/2016quarterly$0.193.84%11/3/201611/7/201611/18/2016
7/25/2016quarterly$0.193.71%8/4/20168/8/20168/19/2016
5/9/2016quarterly$0.193.9%5/18/20165/20/20165/27/2016
1/25/2016quarterly$0.184.04%2/4/20162/8/20162/19/2016
10/19/2015quarterly$0.184.28%10/29/201511/2/201511/13/2015
7/20/2015quarterly$0.184.23%7/30/20158/3/20158/14/2015
5/4/2015quarterly$0.184.41%5/13/20155/15/20155/22/2015
1/20/2015quarterly$0.174.2%1/30/20152/3/20152/13/2015
10/20/2014quarterly$0.1710/30/201411/3/201411/14/2014
7/21/2014quarterly$0.174.79%7/31/20148/4/20148/15/2014
5/5/2014quarterly$0.175.22%5/14/20145/16/20145/23/2014
1/30/2014quarterly$0.175.14%2/10/20142/12/20142/21/2014
10/28/2013quarterly$0.174.56%11/6/201311/8/201311/22/2013
7/26/2013quarterly$0.174.16%8/8/20138/12/20138/23/2013
5/3/2013quarterly$0.154.65%5/13/20135/15/20135/24/2013
1/28/2013quarterly$0.154.64%2/6/20132/8/20132/22/2013
(Data available from 1/1/2013 forward)

Insider Trades

Petmed Express (NASDAQ PETS) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 4.00%
Institutional Ownership Percentage: 92.01%
Insider Trades by Quarter for Petmed Express (NASDAQ:PETS)
Institutional Ownership by Quarter for Petmed Express (NASDAQ:PETS)

Petmed Express (NASDAQ PETS) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/29/2018Ronald J KornDirectorSell5,000$48.38$241,900.0068,833View SEC Filing  
1/22/2018Menderes AkdagCEOSell10,000$57.00$570,000.00470,000View SEC Filing  
1/11/2018Menderes AkdagCEOSell30,000$51.00$1,530,000.00490,000View SEC Filing  
12/15/2017Gian FulgoniDirectorSell20,000$44.38$887,600.0055,900View SEC Filing  
10/27/2017Ronald J KornDirectorSell1,000$35.57$35,570.0073,833View SEC Filing  
8/1/2017Robert C SchweitzerDirectorSell2,500$49.18$122,950.0088,834View SEC Filing  
7/28/2017Ronald J KornDirectorSell5,000$48.18$240,900.0067,333View SEC Filing  
7/27/2017Bruce S RosenbloomCFOSell6,833$50.18$342,879.9418,534View SEC Filing  
7/27/2017Robert C SchweitzerDirectorSell5,000$48.60$243,000.0083,834View SEC Filing  
5/16/2017Frank J FormicaDirectorSell5,000$35.32$176,600.0046,000View SEC Filing  
5/10/2017Gian FulgoniDirectorSell35,000$32.22$1,127,700.0068,400View SEC Filing  
5/8/2017Bruce S RosenbloomInsiderSell9,000$27.00$243,000.0025,267View SEC Filing  
5/1/2017Bruce S RosenbloomInsiderSell1,500$24.00$36,000.0034,267View SEC Filing  
12/13/2016Menderes AkdagCEOSell10,000$23.00$230,000.00520,000View SEC Filing  
12/9/2016Bruce S RosenbloomInsiderSell1,500$23.00$34,500.0035,767View SEC Filing  
12/7/2016Menderes AkdagCEOSell3,107$22.75$70,684.25532,674View SEC Filing  
11/25/2016Menderes AkdagCEOSell6,274$22.25$139,596.50550,000View SEC Filing  
11/16/2016Frank J FormicaDirectorSell10,000$21.75$217,500.0051,000View SEC Filing  
11/14/2016Bruce S RosenbloomInsiderSell3,000$21.75$65,250.0038,767View SEC Filing  
11/14/2016Menderes AkdagCEOSell40,000$21.63$865,200.00590,000View SEC Filing  
10/10/2016Bruce S RosenbloomInsiderSell1,500$21.00$31,500.0041,767View SEC Filing  
10/10/2016Menderes AkdagCEOSell10,000$21.00$210,000.00600,000View SEC Filing  
9/22/2016Menderes AkdagCEOSell10,000$20.75$207,500.00610,000View SEC Filing  
8/12/2016Bruce S RosenbloomInsiderSell8,000$20.38$163,040.0043,267View SEC Filing  
8/11/2016Robert C SchweitzerDirectorSell3,000$20.59$61,770.0090,334View SEC Filing  
8/9/2016Robert C SchweitzerDirectorSell4,500$20.52$92,340.0094,834View SEC Filing  
8/1/2016Ronald J KornDirectorSell4,000$20.76$83,040.0075,333View SEC Filing  
5/9/2016Bruce S RosenbloomCFOSell5,500$19.54$107,470.0044,767View SEC Filing  
3/30/2016Bruce S RosenbloomCFOSell1,500$18.00$27,000.0046,267View SEC Filing  
3/14/2016Bruce S RosenbloomCFOSell3,000$17.25$51,750.0049,267View SEC Filing  
2/22/2016Ronald J KornDirectorSell5,000$16.76$83,800.0071,833View SEC Filing  
1/22/2016Bruce S RosenbloomCFOSell750$18.50$13,875.0050,767View SEC Filing  
11/20/2015Ronald J KornDirectorSell1,000$17.01$17,010.0076,833View SEC Filing  
7/14/2015Bruce S RosenbloomCFOSell400$18.25$7,300.00View SEC Filing  
7/13/2015Bruce S RosenbloomCFOSell100$18.25$1,825.00View SEC Filing  
6/19/2015Bruce S RosenbloomCFOSell1,000$17.88$17,880.00View SEC Filing  
6/19/2015Menderes AkdagCEOSell8,000$17.75$142,000.00View SEC Filing  
6/4/2015Menderes AkdagCEOSell9,930$17.50$173,775.00View SEC Filing  
5/8/2015Frank J FormicaDirectorSell7,500$16.51$123,825.00View SEC Filing  
4/23/2015Menderes AkdagCEOSell10,000$17.25$172,500.00View SEC Filing  
4/20/2015Menderes AkdagCEOSell10,000$17.00$170,000.00View SEC Filing  
4/13/2015Menderes AkdagCEOSell7,499$16.75$125,608.25View SEC Filing  
4/13/2015Ronald J KornDirectorSell2,000$16.75$33,500.00View SEC Filing  
4/8/2015Menderes AkdagCEOSell2,501$16.75$41,891.75View SEC Filing  
3/30/2015Menderes AkdagCEOSell10,000$16.50$165,000.00View SEC Filing  
3/25/2015Ronald J KornDirectorSell2,000$16.25$32,500.00View SEC Filing  
1/21/2015Menderes AkdagCEOSell60,000$15.63$937,800.00View SEC Filing  
1/20/2015Bruce S RosenbloomCFOSell2,167$15.40$33,371.80View SEC Filing  
8/15/2014Ronald J KornDirectorSell2,000$14.13$28,260.00View SEC Filing  
7/22/2014Bruce S RosenbloomCFOSell1,000$14.13$14,130.00View SEC Filing  
7/21/2014Bruce S RosenbloomCFOSell500$14.00$7,000.00View SEC Filing  
6/12/2014Bruce S RosenbloomCFOSell1,500$13.50$20,250.00View SEC Filing  
9/13/2013Menderes AkdagCEOSell10,000$17.00$170,000.00618,000View SEC Filing  
9/11/2013Bruce S RosenbloomCFOSell6,666$16.21$108,055.86View SEC Filing  
8/14/2013Ronald KornDirectorSell1,000$16.25$16,250.0072,833View SEC Filing  
8/12/2013Ronald KornDirectorSell1,000$16.18$16,180.0073,833View SEC Filing  
7/31/2013Frank J FormicaDirectorSell7,000$16.39$114,730.00View SEC Filing  
7/22/2013Bruce S RosenbloomCFOSell6,250$16.74$104,625.00View SEC Filing  
3/6/2013Ronald J KornDirectorSell2,000$13.50$27,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Petmed Express (NASDAQ PETS) News Headlines

Source:
DateHeadline
Petmed Express Inc (PETS) Expected to Post Quarterly Sales of $67.64 MillionPetmed Express Inc (PETS) Expected to Post Quarterly Sales of $67.64 Million
www.americanbankingnews.com - February 17 at 10:26 AM
 Brokerages Expect Petmed Express Inc (PETS) to Announce $0.43 EPS Brokerages Expect Petmed Express Inc (PETS) to Announce $0.43 EPS
www.americanbankingnews.com - February 15 at 11:10 AM
Petmed Express Inc (PETS) Given Average Rating of "Hold" by BrokeragesPetmed Express Inc (PETS) Given Average Rating of "Hold" by Brokerages
www.americanbankingnews.com - February 15 at 1:46 AM
DaVita (DVA) Beats Q4 Earnings Estimates, Misses RevenuesDaVita (DVA) Beats Q4 Earnings Estimates, Misses Revenues
finance.yahoo.com - February 14 at 8:58 AM
GNC Holdings (GNC) Tops Q4 Earnings, Lags Revenue EstimatesGNC Holdings (GNC) Tops Q4 Earnings, Lags Revenue Estimates
finance.yahoo.com - February 14 at 8:58 AM
Cardiovascular Systems (CSII) Q2 Earnings Top, Revenues LagCardiovascular Systems (CSII) Q2 Earnings Top, Revenues Lag
finance.yahoo.com - February 8 at 3:38 PM
Bull Of The Day PetMed Express (PETS)Bull Of The Day PetMed Express (PETS)
finance.yahoo.com - February 7 at 8:40 AM
Top Stock Picks for the Week of February 5thTop Stock Picks for the Week of February 5th
finance.yahoo.com - February 6 at 3:37 PM
Should You Be Tempted To Buy PetMed Express Inc (NASDAQ:PETS) At Its Current PE Ratio?Should You Be Tempted To Buy PetMed Express Inc (NASDAQ:PETS) At Its Current PE Ratio?
finance.yahoo.com - February 5 at 3:36 PM
Investing Lessons From My Hate Mail - Investorplace.comInvesting Lessons From My Hate Mail - Investorplace.com
www.investorplace.com - February 3 at 8:40 AM
PetMed Express, Inc. (PETS) Ex-Dividend Date Scheduled for February 02, 2018 - NasdaqPetMed Express, Inc. (PETS) Ex-Dividend Date Scheduled for February 02, 2018 - Nasdaq
www.nasdaq.com - February 3 at 8:40 AM
Omnicell (OMCL) Earnings Beat, Revenues Miss Estimates in Q4Omnicell (OMCL) Earnings Beat, Revenues Miss Estimates in Q4
finance.yahoo.com - February 2 at 3:42 PM
Ex-Dividend Alert: PetMed Express Raised its Dividend by 25%; Will Trade Ex-Dividend on February 02, 2018Ex-Dividend Alert: PetMed Express Raised its Dividend by 25%; Will Trade Ex-Dividend on February 02, 2018
finance.yahoo.com - February 1 at 9:01 AM
Wired News – Aradigm Announced Rejection of Linhaliq(TM)’s New Drug Application by FDAWired News – Aradigm Announced Rejection of Linhaliq(TM)’s New Drug Application by FDA
finance.yahoo.com - January 31 at 8:52 AM
Insider Selling: Petmed Express Inc (PETS) Director Sells 5,000 Shares of StockInsider Selling: Petmed Express Inc (PETS) Director Sells 5,000 Shares of Stock
www.americanbankingnews.com - January 30 at 12:11 PM
Analysis: Positioning to Benefit within PetMed Express, Omnicell, SITO Mobile, INDIA FUND INC, Forum Energy Technologies, and Kirklands — Research Highlights Growth, Revenue, and Consolidated ResultsAnalysis: Positioning to Benefit within PetMed Express, Omnicell, SITO Mobile, INDIA FUND INC, Forum Energy Technologies, and Kirkland's — Research Highlights Growth, Revenue, and Consolidated Results
finance.yahoo.com - January 30 at 8:40 AM
ResMed (RMD) Rides on Product Launches, Robust Global GrowthResMed (RMD) Rides on Product Launches, Robust Global Growth
finance.yahoo.com - January 29 at 3:39 PM
Zacks: Analysts Expect Petmed Express Inc (PETS) Will Announce Earnings of $0.43 Per ShareZacks: Analysts Expect Petmed Express Inc (PETS) Will Announce Earnings of $0.43 Per Share
www.americanbankingnews.com - January 29 at 1:14 PM
Shareholder lawsuit against PetMed Express over short seller report voluntarily dismissedShareholder lawsuit against PetMed Express over short seller report voluntarily dismissed
finance.yahoo.com - January 24 at 3:45 PM
Brokers Offer Predictions for PetMed Express, Inc.s Q3 2018 Earnings (PETS)Brokers Offer Predictions for PetMed Express, Inc.'s Q3 2018 Earnings (PETS)
www.americanbankingnews.com - January 24 at 1:56 PM
PetMed Express, Inc. (PETS) CEO Menderes Akdag Sells 10,000 SharesPetMed Express, Inc. (PETS) CEO Menderes Akdag Sells 10,000 Shares
www.americanbankingnews.com - January 24 at 12:38 PM
Petmed Express Inc Stock Clearly Is Way Overpriced - Investorplace.comPetmed Express Inc Stock Clearly Is Way Overpriced - Investorplace.com
investorplace.com - January 24 at 8:18 AM
PetMed Express: $48 Somehow Seems About Right - Seeking AlphaPetMed Express: $48 Somehow Seems About Right - Seeking Alpha
seekingalpha.com - January 24 at 8:18 AM
Research Analysts Set Expectations for PetMed Express, Inc.s FY2018 Earnings (PETS)Research Analysts Set Expectations for PetMed Express, Inc.'s FY2018 Earnings (PETS)
www.americanbankingnews.com - January 23 at 3:38 PM
PetMed Express D/B/A 1-800-PetMeds Announces Its Third Quarter Financial Results and Increased Its Quarterly Dividend by 25% to $0.25 per SharePetMed Express D/B/A 1-800-PetMeds Announces Its Third Quarter Financial Results and Increased Its Quarterly Dividend by 25% to $0.25 per Share
finance.yahoo.com - January 22 at 3:48 PM
PetMed Initially Rockets On Strong Earnings, But Later FlopsPetMed Initially Rockets On Strong Earnings, But Later Flops
finance.yahoo.com - January 22 at 3:48 PM
PetMeds stock soars toward record high after earnings beat, raised dividendPetMed's stock soars toward record high after earnings beat, raised dividend
finance.yahoo.com - January 22 at 3:48 PM
Petmed Bears Are HurtingPetmed Bears Are Hurting
finance.yahoo.com - January 22 at 3:48 PM
PetMed Express, Inc. (PETS) to Issue Dividend Increase - $0.25 Per SharePetMed Express, Inc. (PETS) to Issue Dividend Increase - $0.25 Per Share
www.americanbankingnews.com - January 22 at 8:56 AM
PetMed Express (PETS) Announces  Earnings ResultsPetMed Express (PETS) Announces Earnings Results
www.americanbankingnews.com - January 22 at 8:52 AM
Earnings Scheduled For January 22, 2018 - BenzingaEarnings Scheduled For January 22, 2018 - Benzinga
www.benzinga.com - January 22 at 5:28 AM
Pre-Market Earnings Report for January 22, 2018 : HAL, BOH, CBU, PETS, OPB, TBK, BMRC - NasdaqPre-Market Earnings Report for January 22, 2018 : HAL, BOH, CBU, PETS, OPB, TBK, BMRC - Nasdaq
www.nasdaq.com - January 21 at 2:32 PM
BidaskClub Downgrades PetMed Express (PETS) to BuyBidaskClub Downgrades PetMed Express (PETS) to Buy
www.americanbankingnews.com - January 21 at 2:16 PM
PetMed Express, Inc. (PETS) Receives Average Rating of "Hold" from AnalystsPetMed Express, Inc. (PETS) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - January 21 at 1:38 AM
PetMed Express At Top End Of Buy Range With Earnings DuePetMed Express At Top End Of Buy Range With Earnings Due
finance.yahoo.com - January 16 at 4:43 PM
PetMed Express D/B/A 1-800-PetMeds to Announce Its Third Quarter Financial Results on January 22, 2018PetMed Express D/B/A 1-800-PetMeds to Announce Its Third Quarter Financial Results on January 22, 2018
finance.yahoo.com - January 16 at 10:11 AM
PetMed Express, Inc. (PETS) CEO Sells $1,530,000.00 in StockPetMed Express, Inc. (PETS) CEO Sells $1,530,000.00 in Stock
www.americanbankingnews.com - January 16 at 6:24 AM
PetMed Express (PETS) to Release Earnings on MondayPetMed Express (PETS) to Release Earnings on Monday
www.americanbankingnews.com - January 15 at 2:40 AM
PetMed Express, Inc. (PETS) Expected to Post Quarterly Sales of $57.02 MillionPetMed Express, Inc. (PETS) Expected to Post Quarterly Sales of $57.02 Million
www.americanbankingnews.com - January 14 at 6:30 AM
$0.36 EPS Expected for PetMed Express, Inc. (PETS) This Quarter$0.36 EPS Expected for PetMed Express, Inc. (PETS) This Quarter
www.americanbankingnews.com - January 12 at 3:26 PM
Top Ranked Growth Stocks to Buy for January 9thTop Ranked Growth Stocks to Buy for January 9th
www.zacks.com - January 9 at 10:06 AM
Highly Rated PetMed Express Near Buy Zone Before Next Earnings ReportHighly Rated PetMed Express Near Buy Zone Before Next Earnings Report
finance.yahoo.com - January 8 at 4:50 PM
Zacks.com highlights: PetMed Express, SMART Global Holdings and Delek US HoldingsZacks.com highlights: PetMed Express, SMART Global Holdings and Delek US Holdings
finance.yahoo.com - January 4 at 10:07 AM
Northcoast Research Reiterates "Buy" Rating for PetMed Express (PETS)Northcoast Research Reiterates "Buy" Rating for PetMed Express (PETS)
www.americanbankingnews.com - January 3 at 5:40 PM
PetMed Rides on Solid Reorders & New Orders Amid CompetitionPetMed Rides on Solid Reorders & New Orders Amid Competition
finance.yahoo.com - January 2 at 10:04 AM
Zacks: Brokerages Anticipate PetMed Express, Inc. (PETS) Will Post Quarterly Sales of $57.02 MillionZacks: Brokerages Anticipate PetMed Express, Inc. (PETS) Will Post Quarterly Sales of $57.02 Million
www.americanbankingnews.com - December 29 at 9:56 PM
ETFs with exposure to PetMed Express, Inc. : December 29, 2017ETFs with exposure to PetMed Express, Inc. : December 29, 2017
finance.yahoo.com - December 29 at 4:39 PM
Patterson Companies (PDCO) Dental Segment Shows Weakness - NasdaqPatterson Companies' (PDCO) Dental Segment Shows Weakness - Nasdaq
www.nasdaq.com - December 28 at 4:40 PM
PetMed Express, Inc. :PETS-US: Earnings Analysis: Q2, 2018 By the Numbers : December 28, 2017PetMed Express, Inc. :PETS-US: Earnings Analysis: Q2, 2018 By the Numbers : December 28, 2017
finance.yahoo.com - December 28 at 4:40 PM
Invesors May Take a Look at PetMedInvesors May Take a Look at PetMed
finance.yahoo.com - December 21 at 4:46 PM

SEC Filings

Petmed Express (NASDAQ:PETS) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Petmed Express (NASDAQ:PETS) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Petmed Express (NASDAQ PETS) Stock Chart for Thursday, February, 22, 2018

Loading chart…

This page was last updated on 2/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.